From: Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients
 | Overall survival | Disease free survival | ||||||
---|---|---|---|---|---|---|---|---|
 | Cox Regression | Cox Regression | ||||||
 | HR | 95%CI | p-value | HR | 95%CI | p-value | ||
MSI | 0.38 | 0.12 | 1.18 | 0.09 | 0.33 | 0.09 | 1.27 | 0.11 |
Age | 1.04 | 1.00 | 1.07 | 0.04 | 0.97 | 0.92 | 1.01 | 0.14 |
Gender | 1.41 | 0.79 | 2.53 | 0.25 | 1.45 | 0.68 | 3.13 | 0.34 |
Localization | 0.71 | 0.38 | 1.31 | 0.27 | 1.16 | 0.47 | 2.84 | 0.75 |
Grade of differentiation | 0.70 | 0.43 | 1.13 | 0.15 | 0.53 | 0.34 | 1.09 | 0.05 |
stage | 2.37 | 1.58 | 3.56 | < 0.001 | 2.70 | 1.51 | 4.83 | < 0.001 |
adjuvant treatment | 0.70 | 0.29 | 1.68 | 0.43 | 1.03 | 0.36 | 2.97 | 0.96 |
CD8IM | 1.24 | 0.56 | 2.75 | 0.59 | 0.82 | 0.29 | 2.36 | 0.71 |
CD8ST | 0.89 | 0.38 | 2.10 | 0.79 | 1.95 | 0.66 | 5.76 | 0.22 |
CD8CC | 2.06 | 0.67 | 6.39 | 0.21 | 0.68 | 0.16 | 2.88 | 0.60 |
CD3IM | 0.97 | 0.40 | 2.32 | 0.94 | 0.86 | 0.27 | 2.75 | 0.80 |
CD3ST | 1.05 | 0.51 | 2.19 | 0.89 | 0.66 | 0.24 | 1.85 | 0.43 |
CD3CC | 0.54 | 0.18 | 1.59 | 0.26 | 1.61 | 0.44 | 5.95 | 0.48 |
GRBIM | 0.59 | 0.24 | 1.44 | 0.24 | 1.14 | 0.37 | 3.52 | 0.81 |
GRBST | 0.86 | 0.37 | 2.00 | 0.72 | 0.53 | 0.17 | 1.65 | 0.27 |
GRBCC | 1.18 | 0.45 | 3.13 | 0.74 | 2.18 | 0.62 | 7.61 | 0.22 |